<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38026427</PMID><DateCompleted><Year>2023</Year><Month>12</Month><Day>01</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>28</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2296-2565</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in public health</Title><ISOAbbreviation>Front Public Health</ISOAbbreviation></Journal><ArticleTitle>The importance of estimating prevalence of ME/CFS in future epidemiological studies of long COVID.</ArticleTitle><Pagination><StartPage>1275827</StartPage><MedlinePgn>1275827</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1275827</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fpubh.2023.1275827</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Grabowska</LastName><ForeName>Anna D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Department of Biophysics, Physiology, and Pathophysiology, Medical University of Warsaw, Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Westermeier</LastName><ForeName>Francisco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Health Studies, Institute of Biomedical Science, FH Joanneum University of Applied Sciences, Graz, Austria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro Integrativo de Biolog&#xed;a y Qu&#xed;mica Aplicada (CIBQA), Universidad Bernardo O'Higgins, Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nacul</LastName><ForeName>Lu&#xed;s</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Women's Health Research Institute and BC Women's Hospital, University of British Columbia (BC), Vancouver, BC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lacerda</LastName><ForeName>Eliana</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sep&#xfa;lveda</LastName><ForeName>Nuno</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Faculty of Mathematics &amp; Information Science, Warsaw University of Technology, Warsaw, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CEAUL - Centro de Estat&#xed;stica e Aplica&#xe7;&#xf5;es da Universidade de Lisboa, Lisbon, Portugal.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AI170839</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI170839</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>11</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Public Health</MedlineTA><NlmUniqueID>101616579</NlmUniqueID><ISSNLinking>2296-2565</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015673" MajorTopicYN="Y">Fatigue Syndrome, Chronic</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016021" MajorTopicYN="N">Epidemiologic Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ME/CFS</Keyword><Keyword MajorTopicYN="N">diagnostic criteria</Keyword><Keyword MajorTopicYN="N">disease duration</Keyword><Keyword MajorTopicYN="N">fatigue</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">post-exertional malaise</Keyword><Keyword MajorTopicYN="N">prevalence</Keyword><Keyword MajorTopicYN="N">unrefreshing sleep</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>8</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>10</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>1</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>11</Month><Day>29</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>29</Day><Hour>16</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>11</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38026427</ArticleId><ArticleId IdType="pmc">PMC10654790</ArticleId><ArticleId IdType="doi">10.3389/fpubh.2023.1275827</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. (2023) 21:133&#x2013;46. 10.1038/s41579-022-00846-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. (2022) 22:e102&#x2013;7. 10.1016/S1473-3099(21)00703-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. . Post-acute COVID-19 syndrome. Nat Med. (2021) 27:601&#x2013;15. 10.1038/s41591-021-01283-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherif ZA, Gomez CR, Connors TJ, Henrich TJ, Reeves WB. Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC). Elife. (2023) 12:e86002. 10.7554/eLife.86002</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.86002</ArticleId><ArticleId IdType="pmc">PMC10032659</ArticleId><ArticleId IdType="pubmed">36947108</ArticleId></ArticleIdList></Reference><Reference><Citation>Oronsky B, Larson C, Hammond TC, Oronsky A, Kesari S, Lybeck M, et al. . Review of persistent post-COVID syndrome (PPCS). Clin Rev Allergy Immunol. (2023) 64:66&#x2013;74. 10.1007/s12016-021-08848-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-021-08848-3</ArticleId><ArticleId IdType="pmc">PMC7896544</ArticleId><ArticleId IdType="pubmed">33609255</ArticleId></ArticleIdList></Reference><Reference><Citation>The Lancet . Long COVID: 3 years in. Lancet. (2023) 401:795. 10.1016/S0140-6736(23)00493-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(23)00493-2</ArticleId><ArticleId IdType="pmc">PMC9998094</ArticleId><ArticleId IdType="pubmed">36906338</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re'em Y, et al. . Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. (2021) 38:101019. 10.1016/j.eclinm.2021.101019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Altmann DM, Whettlock EM, Liu S, Arachchillage DJ, Boyton RJ. The immunology of long COVID. Nat Rev Immunol. (2023) 23:618&#x2013;34. 10.1038/s41577-023-00904-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-023-00904-7</ArticleId><ArticleId IdType="pubmed">37433988</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Mahoney LL, Routen A, Gillies C, Ekezie W, Welford A, Zhang A, et al. . The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: a systematic review and meta-analysis. EClinicalMedicine. (2022) 55:101762. 10.1016/j.eclinm.2022.101762</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101762</ArticleId><ArticleId IdType="pmc">PMC9714474</ArticleId><ArticleId IdType="pubmed">36474804</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodrow M, Carey C, Ziauddeen N, Thomas R, Akrami A, Lutje V, et al. . Systematic review of the prevalence of long COVID. Open Forum Infect Dis. (2023) 10:ofad233. 10.1093/ofid/ofad233</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofad233</ArticleId><ArticleId IdType="pmc">PMC10316694</ArticleId><ArticleId IdType="pubmed">37404951</ArticleId></ArticleIdList></Reference><Reference><Citation>Natarajan A, Shetty A, Delanerolle G, Zeng Y, Zhang Y, Raymont V, et al. . A systematic review and meta-analysis of long COVID symptoms. Syst Rev. (2023) 12:88. 10.1186/s13643-023-02250-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13643-023-02250-0</ArticleId><ArticleId IdType="pmc">PMC10220332</ArticleId><ArticleId IdType="pubmed">37245047</ArticleId></ArticleIdList></Reference><Reference><Citation>Est&#xe9;vez-L&#xf3;pez F, Mudie K, Wang-Steverding X, Bakken IJ, Ivanovs A, Castro-Marrero J, et al. . Systematic review of the epidemiological burden of myalgic encephalomyelitis/chronic fatigue syndrome across Europe: current evidence and EUROMENE research recommendations for epidemiology. J Clin Med. (2020) 9:1557. 10.3390/jcm9051557</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9051557</ArticleId><ArticleId IdType="pmc">PMC7290765</ArticleId><ArticleId IdType="pubmed">32455633</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim EJ, Ahn YC, Jang ES, Lee SW, Lee SH, Son CG. Systematic review and meta-analysis of the prevalence of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME). J Transl Med. (2020) 18:100. 10.1186/s12967-020-02269-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-020-02269-0</ArticleId><ArticleId IdType="pmc">PMC7038594</ArticleId><ArticleId IdType="pubmed">32093722</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheibenbogen C, Freitag H, Blanco J, Capelli E, Lacerda E, Authier J, et al. . The European ME/CFS biomarker landscape project: an initiative of the European network EUROMENE. J Transl Med. (2017) 15:162. 10.1186/s12967-017-1263-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-017-1263-z</ArticleId><ArticleId IdType="pmc">PMC5530475</ArticleId><ArticleId IdType="pubmed">28747192</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff AL, Lipkin WI. Insights from myalgic encephalomyelitis/chronic fatigue syndrome may help unravel the pathogenesis of postacute COVID-19 syndrome. Trends Mol Med. (2021) 27:895&#x2013;906. 10.1016/j.molmed.2021.06.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2021.06.002</ArticleId><ArticleId IdType="pmc">PMC8180841</ArticleId><ArticleId IdType="pubmed">34175230</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff AL, Lipkin WI. ME/CFS and Long COVID share similar symptoms and biological abnormalities: road map to the literature. Front Med. (2023) 10:1187163. 10.3389/fmed.2023.1187163</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1187163</ArticleId><ArticleId IdType="pmc">PMC10278546</ArticleId><ArticleId IdType="pubmed">37342500</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong TL, Weitzer DJ. Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)-A systemic review and comparison of clinical presentation and symptomatology. Medicina. (2021) 57:418. 10.3390/medicina57050418</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina57050418</ArticleId><ArticleId IdType="pmc">PMC8145228</ArticleId><ArticleId IdType="pubmed">33925784</ArticleId></ArticleIdList></Reference><Reference><Citation>Legler F, Meyer-Arndt L, M&#xf6;dl L, Kedor C, Freitag H, Stein E, et al. . Long-term symptom severity and clinical biomarkers in post-COVID-19/chronic fatigue syndrome: results from a prospective observational cohort. EClinicalMedicine. (2023) 63:102146. 10.1016/j.eclinm.2023.102146</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2023.102146</ArticleId><ArticleId IdType="pmc">PMC10469383</ArticleId><ArticleId IdType="pubmed">37662515</ArticleId></ArticleIdList></Reference><Reference><Citation>Pheby DFH, Araja D, Berkis U, Brenna E, Cullinan J, de Korwin J-D, et al. . The development of a consistent Europe-Wide approach to investigating the economic impact of myalgic encephalomyelitis (ME/CFS): a report from the European Network on ME/CFS (EUROMENE). Healthcare. (2020) 8:88. 10.3390/healthcare8020088</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare8020088</ArticleId><ArticleId IdType="pmc">PMC7349118</ArticleId><ArticleId IdType="pubmed">32272608</ArticleId></ArticleIdList></Reference><Reference><Citation>Haffke M, Freitag H, Rudolf G, Seifert M, Doehner W, Scherbakov N, et al. . Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS). J Transl Med. (2022) 20:138. 10.1186/s12967-022-03346-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-022-03346-2</ArticleId><ArticleId IdType="pmc">PMC8938726</ArticleId><ArticleId IdType="pubmed">35317812</ArticleId></ArticleIdList></Reference><Reference><Citation>Flaskamp L, Roubal C, Uddin S, Sotzny F, Kedor C, Bauer S, et al. . Serum of post-COVID-19 syndrome patients with or without ME/CFS differentially affects endothelial cell function in vitro. Cells. (2022) 11:2376. 10.3390/cells11152376</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11152376</ArticleId><ArticleId IdType="pmc">PMC9367589</ArticleId><ArticleId IdType="pubmed">35954219</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayes LD, Sanal-Hayes NEM, Mclaughlin M, Berry ECJ, Sculthorpe NF. People with long covid and ME/CFS exhibit similarly impaired balance and physical capacity: a case-case-control study. Am J Med. (2023). 10.1016/j.amjmed.2023.06.028</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2023.06.028</ArticleId><ArticleId IdType="pubmed">37490948</ArticleId></ArticleIdList></Reference><Reference><Citation>Mclaughlin M, Sanal-Hayes NEM, Hayes LD, Berry EC, Sculthorpe NF. People with long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) exhibit similarly impaired vascular function. Am J Med. (2023). 10.1016/j.amjmed.2023.09.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2023.09.013</ArticleId><ArticleId IdType="pubmed">37832757</ArticleId></ArticleIdList></Reference><Reference><Citation>Lacerda EM, Bowman EW, Cliff JM, Kingdon CC, King EC, Lee J-S, et al. . The UK ME/CFS biobank for biomedical research on myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and multiple sclerosis. Open J Bioresour. (2017) 4:4. 10.5334/ojb.28</Citation><ArticleIdList><ArticleId IdType="doi">10.5334/ojb.28</ArticleId><ArticleId IdType="pmc">PMC5482226</ArticleId><ArticleId IdType="pubmed">28649428</ArticleId></ArticleIdList></Reference><Reference><Citation>Lacerda EM, Mudie K, Kingdon CC, Butterworth JD, O'Boyle S, Nacul L. The UK ME/CFS biobank: a disease-specific biobank for advancing clinical research into myalgic encephalomyelitis/chronic fatigue syndrome. Front Neurol. (2018) 9:1026. 10.3389/fneur.2018.01026</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2018.01026</ArticleId><ArticleId IdType="pmc">PMC6288193</ArticleId><ArticleId IdType="pubmed">30564186</ArticleId></ArticleIdList></Reference><Reference><Citation>Brurberg KG, F&#xf8;nhus MS, Larun L, Flottorp S, Malterud K. Case definitions for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): a systematic review. BMJ Open. (2014) 4:e003973. 10.1136/bmjopen-2013-003973</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2013-003973</ArticleId><ArticleId IdType="pmc">PMC3918975</ArticleId><ArticleId IdType="pubmed">24508851</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim EJ, Son CG. Review of case definitions for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). J Transl Med. (2020) 18:289. 10.1186/s12967-020-02455-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-020-02455-0</ArticleId><ArticleId IdType="pmc">PMC7391812</ArticleId><ArticleId IdType="pubmed">32727489</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Intern Med. (1994) 121:953&#x2013;9. 10.7326/0003-4819-121-12-199412150-00009</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-121-12-199412150-00009</ArticleId><ArticleId IdType="pubmed">7978722</ArticleId></ArticleIdList></Reference><Reference><Citation>Carruthers BM, Jain AK, De Meirleir KL, Peterson DL, Klimas NG, Lemer AM, et al. . Myalgic encephalomyelitis/chronic fatigue syndrome: clinical working case definition, diagnostic and treatment protocols. J Chronic Fatigue Syndr. (2003) 11:7&#x2013;115. 10.1300/J092v11n01_02</Citation><ArticleIdList><ArticleId IdType="doi">10.1300/J092v11n01_02</ArticleId></ArticleIdList></Reference><Reference><Citation>Nacul L, Authier FJ, Scheibenbogen C, Lorusso L, Helland IB, Martin JA, et al. . European network on myalgic encephalomyelitis/chronic fatigue syndrome (EUROMENE): expert consensus on the diagnosis, service provision, and care of people with ME/CFS in Europe. Medicina. (2021) 57:510. 10.3390/medicina57050510</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina57050510</ArticleId><ArticleId IdType="pmc">PMC8161074</ArticleId><ArticleId IdType="pubmed">34069603</ArticleId></ArticleIdList></Reference><Reference><Citation>Reeves WC, Lloyd A, Vernon SD, Klimas N, Jason LA, Bleijenberg G, et al. . Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution. BMC Health Serv Res. (2003) 3:25. 10.1186/1472-6963-3-25</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1472-6963-3-25</ArticleId><ArticleId IdType="pmc">PMC317472</ArticleId><ArticleId IdType="pubmed">14702202</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason LA, Ravichandran S, Katz BZ, Natelson BH, Bonilla HF. Establishing a consensus on ME/CFS exclusionary illnesses. Fatigue Biomed Heal Behav. (2022) 11:1&#x2013;13. 10.1080/21641846.2022.2150487</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21641846.2022.2150487</ArticleId></ArticleIdList></Reference><Reference><Citation>Munblit D, Nicholson T, Akrami A, Apfelbacher C, Chen J, De Groote W, et al. . A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research: an international Delphi consensus study. Lancet Respir Med. (2022) 10:715&#x2013;24. 10.1016/S2213-2600(22)00169-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00169-2</ArticleId><ArticleId IdType="pmc">PMC9197249</ArticleId><ArticleId IdType="pubmed">35714658</ArticleId></ArticleIdList></Reference><Reference><Citation>Thaweethai T, Jolley SE, Karlson EW, Levitan EB, Levy B, McComsey GA, et al. . Development of a definition of postacute sequelae of SARS-CoV-2 infection. JAMA. (2023) 329:1934. 10.1001/jama.2023.15712</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2023.15712</ArticleId><ArticleId IdType="pmc">PMC10214179</ArticleId><ArticleId IdType="pubmed">37278994</ArticleId></ArticleIdList></Reference><Reference><Citation>Domingues TD, Malato J, Grabowska AD, Lee JS, Ameijeiras-Alonso J, Biecek P, et al. . Association analysis between symptomology and herpesvirus IgG antibody concentrations in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and multiple sclerosis. Heliyon. (2023) 9:e18250. 10.1016/j.heliyon.2023.e18250</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.heliyon.2023.e18250</ArticleId><ArticleId IdType="pmc">PMC10372404</ArticleId><ArticleId IdType="pubmed">37519635</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber KA, Sunnquist M, Jason LA. Latent class analysis of a heterogeneous international sample of patients with myalgic encephalomyelitis/chronic fatigue syndrome. Fatigue Biomed Heal Behav. (2018) 6:163. 10.1080/21641846.2018.1494530</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21641846.2018.1494530</ArticleId><ArticleId IdType="pmc">PMC6703845</ArticleId><ArticleId IdType="pubmed">31435490</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaes AW, Van Herck M, Deng Q, Delbressine JM, Jason LA, Spruit MA. Symptom-based clusters in people with ME/CFS: an illustration of clinical variety in a cross-sectional cohort. J Transl Med. (2023) 21:112. 10.1186/s12967-023-03946-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-023-03946-6</ArticleId><ArticleId IdType="pmc">PMC9921324</ArticleId><ArticleId IdType="pubmed">36765375</ArticleId></ArticleIdList></Reference><Reference><Citation>Nacul L, O'Boyle S, Palla L, Nacul FE, Mudie K, Kingdon CC, et al. . How myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) progresses: the natural history of ME/CFS. Front Neurol. (2020) 11:826. 10.3389/fneur.2020.00826</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.00826</ArticleId><ArticleId IdType="pmc">PMC7431524</ArticleId><ArticleId IdType="pubmed">32849252</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason LA, Sunnquist M. The development of the DePaul symptom questionnaire: original, expanded, brief, and pediatric versions. Front Pediatr. (2018) 6:330. 10.3389/fped.2018.00330</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2018.00330</ArticleId><ArticleId IdType="pmc">PMC6232226</ArticleId><ArticleId IdType="pubmed">30460215</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason LA, Holtzman CS, Sunnquist M, Cotler J. The development of an instrument to assess post-exertional malaise in patients with myalgic encephalomyelitis and chronic fatigue syndrome. J Health Psychol. (2021) 26:238. 10.1177/1359105318805819</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1359105318805819</ArticleId><ArticleId IdType="pmc">PMC7988339</ArticleId><ArticleId IdType="pubmed">30354489</ArticleId></ArticleIdList></Reference><Reference><Citation>Cotler J, Holtzman C, Dudun C, Jason LA. A brief questionnaire to assess post-exertional malaise. Diagnostics. (2018) 8:66. 10.3390/diagnostics8030066</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics8030066</ArticleId><ArticleId IdType="pmc">PMC6165517</ArticleId><ArticleId IdType="pubmed">30208578</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason LA, Unger ER, Dimitrakoff JD, Fagin AP, Houghton M, Cook DB, et al. . Minimum data elements for research reports on CFS. Brain Behav Immun. (2012) 26:401. 10.1016/j.bbi.2012.01.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2012.01.014</ArticleId><ArticleId IdType="pmc">PMC4643273</ArticleId><ArticleId IdType="pubmed">22306456</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonilla H, Quach TC, Tiwari A, Bonilla AE, Miglis M, Yang PC, et al. . Myalgic encephalomyelitis/chronic fatigue syndrome is common in post-acute sequelae of SARS-CoV-2 infection (PASC): results from a post-COVID-19 multidisciplinary clinic. Front Neurol. (2023) 14:1090747. 10.3389/fneur.2023.1090747</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2023.1090747</ArticleId><ArticleId IdType="pmc">PMC9998690</ArticleId><ArticleId IdType="pubmed">36908615</ArticleId></ArticleIdList></Reference><Reference><Citation>Grabowska AD, Lacerda EM, Nacul L, Sep&#xfa;lveda N. Review of the quality control checks performed by current genome-wide and targeted-genome association studies on myalgic encephalomyelitis/chronic fatigue syndrome. Front Pediatr. (2020) 8:293. 10.3389/fped.2020.00293</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2020.00293</ArticleId><ArticleId IdType="pmc">PMC7304330</ArticleId><ArticleId IdType="pubmed">32596192</ArticleId></ArticleIdList></Reference><Reference><Citation>Salari N, Khodayari Y, Hosseinian-Far A, Zarei H, Rasoulpoor S, Akbari H, et al. . Global prevalence of chronic fatigue syndrome among long COVID-19 patients: a systematic review and meta-analysis. Biopsychosoc Med. (2022) 16:21. 10.1186/s13030-022-00250-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13030-022-00250-5</ArticleId><ArticleId IdType="pmc">PMC9589726</ArticleId><ArticleId IdType="pubmed">36274177</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirschauer N, Gr&#xfc;ner S, Mu&#xdf;hoff O, Becker C, Jantsch A. Inference using non-random samples? Stop right there! Significance. (2021) 18:20&#x2013;4. 10.1111/1740-9713.01568</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1740-9713.01568</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>